S&P 500
5.214,08 +26,41 (+0,51%) Nasdaq
16.346,26 +43,46 (+0,27%) NIKKEI 225
38.311,63 +237,65 (+0,62%) Dólar/Euro
1,0778 -0,0006 (-0,05%) Petróleo Brent
84,30 +0,42 (+0,50%) Bitcoin EUR
58.361,96 +1.325,46 (+2,32%)
QHSLab, Inc. (USAQ)
QHSLab, Inc.
901 Northpoint Parkway
Suite 302
West Palm Beach, FL 33407
United States
929 379 6503
https://www.usaqcorp.com
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 4
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Troy James Grogan | CEO, CFO, President & Chairman | N/A | N/A | 1977 |
| Olivia Giamanco | Marketing Director | N/A | N/A | N/A |
| Ms. Cyndi Cole CPA, M.B.A. | Financial Controller | N/A | N/A | N/A |
Descripción
QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.
Gobierno corporativo
El ISS Governance QualityScore de QHSLab, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
